Search Results 1991-2000 of 104837 for Cells
Cemiplimab works by helping the immune system to kill cancer cells. It binds to a protein called programmed cell death-1 (PD-1) on the surface of certain immune ...
Stem cell therapy. Dr. Hickson's current research on stem cell therapy for ... Hickson is also studying stem cells in patients with chronic kidney disease.
... cells. This gene is the cystic fibrosis transmembrane conductance regulator (CFTR) gene. It affects the cells that make mucus, sweat and digestive juices.
Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether temozolomide is more effective ...
Targeted therapy uses medicines that focus on specific changes in cancer cells. Some targeted therapies can be effective against brain metastases, depending on ...
Once the protein pieces are made, the cells break down the instructions and get rid of them. The mRNA from the vaccine doesn't enter the nucleus of the cell, ...
... cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as rituximab, can block cancer cells in different ways. Some block ...
Mayo Clinic's Cell and Regenerative Physiology Lab, led by Gary C. Sieck, Ph.D., studies inflammation in reactive oxidant species formation and the ...
SVF cells are a type of cells with the potential to regenerate tissue. Treatment of the glioblastoma has seen little improvement in outcome in the past ...
They become beating, contracting heart muscle cells. It is a nine-month process from cell extraction to the scale up of the hundreds of millions of cells that ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.